explore -WSS

explore

author：comprehensive 2025-08-18 11:30:37 - browse：72

Doctor Monica Bertagnolli, a white woman with short hair and bangs, sits at a hearing behind her name tag — coverage from STAT — National Institutes of Health Director Monica Bertagnolli testifies during her Senate HELP Committee confirmation hearing on Oct. 18 in Washington. Kevin Dietsch/Getty Images

WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry.

“If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”

A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： STAT Readout Newsletter: Today's biggest biotech updates

WSS

Solve the antibiotic resistance crisis with preventive drugs

STAT Summit: Michael J. Fox on progress in Parkinson's research

The new shift in health care is toward less care

Senate panel clears PBM, hopsital reforms

Victims of gun violence feel impacts long after bullet wound

Will Ozempic

hotspot

explore

leisure time

Tori Bowie and the unacceptable rates of Black maternal death

Extreme heat events are a public health emergency

Tori Bowie and the unacceptable rates of Black maternal death

The EU Joint Clinical Assessment needs to live up to its promise

Bright Health sells Medicare Advantage business to Molina

Just how powerful is the placebo effect?

Novavax promises a turnaround & Lilly roils the obesity market

How climate

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Diversify hospital leadership teams to protect BIPOC patient health

explore

FDA struggles to regulate food additives, sometimes for decades

Lawmakers consider Medicare pay reforms for doctors

Solve the antibiotic resistance crisis with preventive drugs

Medicare will require more price transparency from hospitals

Will General Catalyst be the first of many hospital takeovers?

UCSF medical school apologizes for unethical prisoner experiments

Wikipedia

hotspot

hotspot

hotspot